UK launches agreement model to streamline research collaborations
This article was originally published in SRA
The Department of Health in England and Wales has launched a standard agreement to help streamline the contracting process for clinical research collaborations between pharmaceutical companies, universities and the National Health Service1,2.
You may also be interested in...
The European Medicines Agency may decide this week on a dozen requests by companies seeking new uses of their approved drugs.
Regulators in the EU have decided on specific arrangements they plan to employ if sponsors detect and report nitrosamine impurities in their products being sold on the market.
The European Medicines Agency is exploring the feasibility and utility of contacting patients’ organizations for their input as soon as its medicines evaluation committee starts reviewing a new drug.